The Wall Street Journal: J&J to end COVID vaccine manufacturing deal with Emergent Biosolutions

Johnson & Johnson said Monday it planned to terminate its COVID-19 vaccine supply deal with contract manufacturer Emergent BioSolutions Inc., as both companies accused each other of breaching the agreement.

Read More

Previous post Washington DC reports first potential monkeypox case this year
Next post Boris Johnson turns back leadership challenge after 'Partygate' mess